Home

Funicular Fund, LP

CIK 1752618 · last filed 2022-05-16

Funicular Fund, LP is a corporate insider who has filed 10 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider bought $388.3K of ABIO on May 16, 2022. Across all open-market trades the lifetime net is +$1.7M, making them a net buyer over the disclosed history. The firm reports its address in San Francisco, CA. 28 SEC filings were submitted jointly with Cable Car Capital LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

10

Lifetime Open-Market Net

$1.72M

Filer Profile

Reported Address
2261 MARKET STREET
#4307
SAN FRANCISCO, CA 94114
Phone
(415) 857-1965
State of Incorporation
DE
Related Filers
Cable Car Capital LLC — 28 joint filings, latest 2020-10-22
Jacob Ma-Weaver — 13 joint filings, latest 2022-05-25
Funicular Funds, LP — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oruka Therapeutics, Inc. (ABIO) Delisted 206,843 $28.80 $5.96M $1.55M 6 2022-05-16
BLOOMIA HOLDINGS, INC. (ISIG) Delisted 10%+ Owner 216,974 $7.73 $1.68M $175.7K 4 2020-05-08

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-05-16 Oruka Therapeutics, Inc. (ABIO) Delisted Buy (P) +169,672 $388.3K EDGAR
2022-05-11 Oruka Therapeutics, Inc. (ABIO) Delisted Buy (P) +91,150 $208.3K EDGAR
2022-04-20 Oruka Therapeutics, Inc. (ABIO) Delisted Mixed +18,238 $42.2K EDGAR
2022-04-14 Oruka Therapeutics, Inc. (ABIO) Delisted Buy (P) +34,820 $81.1K EDGAR
2022-04-07 Oruka Therapeutics, Inc. (ABIO) Delisted Buy (P) +244,684 $552.6K EDGAR
2022-04-04 Oruka Therapeutics, Inc. (ABIO) Delisted Buy (P) +122,342 $276.3K EDGAR
2020-05-08 BLOOMIA HOLDINGS, INC. (ISIG) Delisted Buy (P) +98 $63 EDGAR
2020-03-27 BLOOMIA HOLDINGS, INC. (ISIG) Delisted Buy (P) +5,112 $3.3K EDGAR
2020-02-05 BLOOMIA HOLDINGS, INC. (ISIG) Delisted Buy (P) +31,314 $25.2K EDGAR
2020-01-17 BLOOMIA HOLDINGS, INC. (ISIG) Delisted Buy (P) +188,222 $147.1K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.